Localization of a novel type trypsin‐like serine protease, neurosin, in brain tissues of Alzheimer's disease and Parkinson's disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Psychiatry and Clinical Neurosciences

• Publication date

  2000-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1046/j.1440-1819.2000.00731.xPMID 10997858
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relative Increase in Alzheimer’s Disease of Soluble Forms of Cerebral Aβ Amyloid Protein Precursor Containing the Kunitz Protease Inhibitory Domain*

  1998cited by this paper
• Serine Proteases in Rodent Hippocampus*

  1998cited by this paper
• Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain.

  1997cited by this paper
• Proteolysis of Alzheimer's disease beta-amyloid precursor protein by factor Xa.

  1997cited by this paper
• Zyme, a Novel and Potentially Amyloidogenic Enzyme cDNA Isolated from Alzheimer’s Disease Brain*

  1997cited by this paper
• Trypsin interaction with the senile plaques of Alzheimer disease is mediated by beta-protein precursor.

  1996cited by this paper
• Coagulation Factor XIa Cleaves the RHDS Sequence and Abolishes the Cell Adhesive Properties of the Amyloid β-Protein (*)

  1995cited by this paper
• Expression and activity-dependent changes of a novel limbic-serine protease gene in the hippocampus

  1995cited by this paper
• Protease Nexin-2/Amyloid β-Protein Precursor Inhibits Factor Xa in the Prothrombinase Complex (*)

  1995cited by this paper
• Full‐Length and Truncated Alzheimer Amyloid Precursors in Chromaffin Granules: Solubilization of Membrane Amyloid Precursor Is Mediated by an Enzymatic Mechanism

  1995cited by this paper
• Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase.

  1994cited by this paper
• Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa.

  1993cited by this paper
• Cloning of the cDNA encoding human brain trypsinogen and characterization of its product.

  1993cited by this paper
• Proteolytic processing of amyloid β protein precursor (APP) by thrombin

  1992cited by this paper
• Thrombin accumulation in brains of patients with Alzheimer's disease.

  1992cited by this paper
• Criteria for diagnosing Parkinson's disease

  1992cited by this paper
• Proteolytic processing of amyloid beta protein precursor (APP) by thrombin.

  1992cited by this paper
• Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor.

  1990cited by this paper
• The protease inhibitory properties of the Alzheimer's beta-amyloid precursor protein.

  1990cited by this paper
• Immune System Response in Alzheimer's Disease

  1989cited by this paper
• Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity

  1988cited by this paper
• Diagnosis of Alzheimer's disease.

  1988cited by this paper
• Diagnosis of Alzheimer's disease.

  1985cited by this paper

• Agrin at the Crossroads of Aging: A Pleiotropic Regulator in Age-Related Diseases.

  2026cites this paper
• Drug Discovery Strategies for Kallikrein-Related Peptidases

  2025cites this paper
• Early diagnosis of Parkinson’s disease: biomarker study

  2025cites this paper
• Analysis of Kallikrein 6, Acetyl-α-Tubulin, and Aquaporin 1 and 2 Expression Patterns During Normal Human Nephrogenesis and in Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)

  2025cites this paper
• Targeting the glymphatic system to promote α-synuclein clearance: a novel therapeutic strategy for Parkinson’s disease

  2025cites this paper
• Multiplex Proteomics of Lewy Body Dementia Reveals Cerebrospinal Fluid Biomarkers of Disease Pathology and Progression

  2025cites this paper
• Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey.

  2024cites this paper
• CNS/PNS proteoglycans functionalize neuronal and astrocyte niche microenvironments optimizing cellular activity by preserving membrane polarization dynamics, ionic microenvironments, ion fluxes, neuronal activation, and network neurotransductive capacity

  2024cites this paper
• Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy

  2023cites this paper
• Scalable synthesis and structural characterization of reversible KLK6 inhibitors

  2022cites this paper
• Proteolytic α-Synuclein Cleavage in Health and Disease

  2021cites this paper
• Proteomics and functional study reveal kallikrein-6 enhances communicating hydrocephalus

  2021cites this paper
• A Novel Mutation of the KLK6 Gene in a Family With Knee Osteoarthritis

  2021cites this paper
• Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1

  2020cites this paper
• Kallikrein 13: a new player in coronaviral infections

  2020cites this paper
• Involvement of Kallikrein-Related Peptidases in Nervous System Disorders

  2020cites this paper
• Spontaneous Post-translational Modification Crosstalk of Proteolysis, Autophagy, and Apoptosis in Aging

  2020cites this paper
• Deficiency of the serine peptidase Kallikrein 6 does not affect the levels and the pathological accumulation of a‐synuclein in mouse brain

  2020cites this paper
• Synthesis and Structure‐Activity Relationships of N‐(4‐Benzamidino)‐Oxazolidinones: Potent and Selective Inhibitors of Kallikrein‐Related Peptidase 6

  2019cites this paper
• How is alpha‐synuclein cleared from the cell?

  2019cites this paper
• Proteomic-based Signature of Brain-related Proteins as Novel Candidate Biomarkers for Alzheimer’s Disease Diagnosis

  2018cites this paper
• Kallikrein-related peptidase 6 orchestrates astrocyte form and function through proteinase activated receptor-dependent mechanisms

  2018cites this paper
• Sensing α‐Synuclein From the Outside via the Prion Protein: Implications for Neurodegeneration

  2018cites this paper
• Cell Biology and Pathophysiology of α-Synuclein.

  2018cites this paper
• Release and uptake of pathologic alpha-synuclein

  2018cites this paper
• Lewy body dementia

  2017cites this paper
• INVESTIGATION OF THE PUTATIVE BIOLOGICAL SUBSTRATES FOR HUMAN KALLIKREIN-RELATED PEPTIDASE 7

  2017cites this paper
• Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy

  2017cites this paper
• Study of kallikrein-related peptidase 6 (KLK6) and its complex with α1-antitrypsin in biological fluids

  2017cites this paper
• Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas

  2016cites this paper
• NEXT GENERATION SEQUENCING DATA IN BOVINE: QUALITY CONTROL, IMPUTATION, AND APPLICATION

  2016cites this paper
• Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology

  2016cites this paper
• Molecular Biomarkers for Diagnosis & Therapies of Alzheimer’s Disease

  2016cites this paper
• Kallikreins - The melting pot of activity and function.

  2016cites this paper
• Rational Design and Optimization of Trypsin Inhibitory Peptides with Antibacterial Activity.

  2015cites this paper
• A Novel Algorithm for Enhanced Structural Motif Matching in Proteins

  2015cites this paper
• The Potential of Pathological Protein Fragmentation in Blood-Based Biomarker Development for Dementia – With Emphasis on Alzheimer’s Disease

  2015cites this paper
• A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy

  2015cites this paper
• Unleashing the therapeutic potential of human kallikrein-related serine proteases

  2015cites this paper
• Synthesis, biological evaluation, and docking studies of PAR2-AP-derived pseudopeptides as inhibitors of kallikrein 5 and 6

  2015cites this paper
• Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases

  2014cites this paper
• Overexpression of the calpain-specific inhibitor calpastatin reduces human alpha-Synuclein processing, aggregation and synaptic impairment in [A30P]αSyn transgenic mice.

  2014cites this paper
• Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1

  2014cites this paper
• Inflammatory cytokine network in schizophrenia

  2014cites this paper
• Investigations into the effects of serine proteases in modulating long lasting depression of synaptic transmission

  2014cites this paper
• Resistance of naturally secreted α‐synuclein to proteolysis

  2014cites this paper
• Proteolytic clearance of extracellular α-synuclein as a new therapeutic approach against Parkinson disease

  2013cites this paper
• Kallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity

  2013cites this paper
• Metastasis of ovarian cancer is mediated by kallikrein related peptidases

  2013cites this paper
• Kallikrein-related Peptidase 6

  2013cites this paper
• Characterization of Kallikrein 6 N-glycosylation Patterns and Identification of Sialylated Glycoproteins in Ovarian Cancer

  2013cites this paper
• Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy

  2013influential citation
• The Impact of Chromosomal Aberrations on the Regulation of Kallikrein 6 Expression in Serous Ovarian Carcinoma

  2013cites this paper
• Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD.

  2013cites this paper
• Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration.

  2013cites this paper
• Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.

  2012cites this paper
• Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship

  2012influential citation
• Kallikrein 6 Regulates Early CNS Demyelination in a Viral Model of Multiple Sclerosis

  2012cites this paper
• The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6)

  2012cites this paper
• Identification, par criblage génomique à haut débit, de Variations du Nombre de Copies impliquées dans les formes précoces de Maladie d'Alzheimer

  2012cites this paper
• Biomarker mRNAs for staging and prognosis of colorectal cancer

  2011cites this paper
• A genome-wide study reveals rare CNVs exclusive to extreme phenotypes of Alzheimer disease

  2011cites this paper
• Plasmatic neurosin as a new potential biomarker in the differential diagnosis of patients with cognitive impairment

  2011cites this paper
• Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia.

  2010cites this paper
• Extracellular neurosin degrades α-synuclein in cultured cells.

  2010cites this paper
• Localization of HtrA2/Omi immunoreactivity in brains affected by Alzheimer’s disease

  2010cites this paper
• Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies.

  2010influential citation
• Kallikrein-related peptidases: proteolysis and signaling in cancer, the new frontier

  2010cites this paper
• Cytokines and schizophrenia: Microglia hypothesis of schizophrenia

  2009cites this paper
• Expression of kallikrein-related peptidases (KRP/hK5, 7, 6, 8) in subtypes of human lung carcinoma.

  2008cites this paper
• KALLIKREIN-RELATED PEPTIDASE SIGNALLING VIA PROTEINASE-ACTIVATED RECEPTORS

  2008cites this paper
• Kallikrein-related peptidases in human epidermis : studies on activity, regulation, and function

  2008cites this paper
• Immunofluorometric activity-based probe analysis of active KLK6 in biological fluids

  2008cites this paper
• Value of Measuring Plasmatic Levels of Neurosin in the Diagnosis of Alzheimer's Disease

  2008cites this paper
• Mosaic serine proteases in the mammalian central nervous system.

  2008cites this paper
• Participation of kallikrein-kinin system in different pathologies.

  2008cites this paper
• Plasmatic level of neurosin predicts outcome of mild cognitive impairment

  2008cites this paper
• The Kallikrein-Related Peptidases hK2 and PSA with Emphasis on Genetic Variation, Secretion, and Sperm Motility

  2008cites this paper
• Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more

  2008cites this paper
• The role of α-synuclein assembly and metabolism in the pathogenesis of Lewy body disease

  2007cites this paper
• The autolytic regulation of human kallikrein-related peptidase 6.

  2007cites this paper
• Novel expression of kallikreins, kallikrein-related peptidases and kinin receptors in human pleural mesothelioma

  2007cites this paper
• Potential scope of action of tissue kallikreins in CNS immune-mediated disease.

  2006cites this paper
• Multiple promoters regulate tissue‐specific alternative splicing of the human kallikrein gene, KLK11/hippostasin

  2006cites this paper
• A novel serine protease highly expressed in the pancreas is expressed in various kinds of cancer cells

  2005cites this paper
• Expression of Myelencephalon-Specific Protease after Cryogenic Lesioning of the Rat Parietal Cortex

  2005cites this paper
• 1.70 Å X‐ray structure of human apo kallikrein 1: Structural changes upon peptide inhibitor/substrate binding

  2005cites this paper
• Human tissue kallikrein gene family: applications in cancer.

  2005cites this paper
• Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.

  2004cites this paper
• Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells

  2004cites this paper
• Molecular cloning and tissue-specific expression analysis of mouse spinesin, a type II transmembrane serine protease 5.

  2004cites this paper
• Expression of myelencephalon-specific protease in transient middle cerebral artery occlusion model of rat brain.

  2004cites this paper
• The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease.

  2004cites this paper
• The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical Biomarkers

  2004cites this paper
• Role of kallikrein enzymes in the central nervous system.

  2003cites this paper
• Characterisation of a recombinant human cysteine dioxygenase

  2003cites this paper
• Human Kallikrein 13 Expression in Normal Tissues: An Immunohistochemical Study

  2003cites this paper
• Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors.

  2003cites this paper
• Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.

  2003cites this paper
• Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals That a Trypsin-like Kallikrein Is Expressed in the Central Nervous System*

  2002cites this paper